JAAD Podcast Winter 2018 - Adalimumab for Nail Psoriasis: Efficacy and Safety from the First 26 Weeks of a Phase-3, Randomized, Placebo-Controlled Trial

As a subscriber to Dialogues in Dermatology premium channel, you will receive new podcasts weekly and can earn CME credit. Listen each week as dermatologists discuss clinical treatments and the latest in dermatology. Dialogues in Dermatology is brought to you by the American Academy of Dermatology.

Share JAAD Podcast Winter 2018 - Adalimumab for Nail Psoriasis: Efficacy and Safety from the First 26 Weeks of a Phase-3, Randomized, Placebo-Controlled Trial

Sign up to save your podcasts

JAAD Podcast Winter 2018 - Adalimumab for Nail Psoriasis: Efficacy and Safety from the First 26 Weeks of a Phase-3, Randomized, Placebo-Controlled Trial

JAAD Podcast Winter 2018 - Adalimumab for Nail Psoriasis: Efficacy and Safety from the First 26 Weeks of a Phase-3, Randomized, Placebo-Controlled Trial

More shows like AAD's Dialogues in Dermatology

How I Built This with Guy Raz

Up First from NPR

JAMA Dermatology Author Interviews

Where Should We Begin? with Esther Perel

Armchair Expert with Dax Shepard

Worklife with Adam Grant

The Peter Attia Drive

The Grenz Zone

Dermasphere - The Dermatology Podcast

Derms and Conditions

We Can Do Hard Things

The Practical Dermatology Podcast

Cutaneous Miscellaneous: The Dermatology Residents Podcast

CME in Minutes: Education in Dermatology

Derms on Drugs